Limiting diaphragm atrophy in intensive care
Mitochondrial fragmentation mechanism that can cause ventilator-induced diaphragm dysfunction (VIDD) found, and a therapeutic to mitigate it.
List view / Grid view
Mitochondrial fragmentation mechanism that can cause ventilator-induced diaphragm dysfunction (VIDD) found, and a therapeutic to mitigate it.
Analysis of cells shows many regions in DNA are differentially activated or inactivated in a cancer-specific manner.
Fatty liver disease treatments may become more effective after identification and greater understanding of more drug targets.
Researchers have engineered CAAR T cells to destroy harmful antibodies, improving NMDA receptor encephalitis treatment.
A $1.2 million grant has been given to observe how Z-RNA is formed and explore its benefits for various diseases.
In rodent and nonhuman primate animals, circuit-specific gene therapy offers promise for Parkinson’s disease and other brain disorders.
Percent necrosis calculated with machine learning model for patients with osteosarcoma provides an accurate prognosis for survival.
Mammary organoid cultures show the effects of BRCA2 mutations on breast tissue cells, increasing the likelihood of early, targeted treatment.
Researchers have improved the method of regenerating heart muscle after a heart attack using a combination of iPSC-derived cells.
Using RNA sequencing, scientists find that metabolic increase in the brain is an early indicator of Alzheimer's disease.
Excessive insulin levels in people with obesity and type 2 diabetes overstimulates pancreatic cells, initiating disease.
Researchers have been able to customise nanoparticles to target biological entities, like tumours and viruses.
Short-chain fatty acids produced by intestinal bacteria initiate dendritic elongation, a mechanism that could be used as a drug target.
Scientists have discovered the motor protein dynein commands movement of cancer cells in soft tissue models, offering new clinical targets.
Researchers have discovered ways to enhance NIR-PIT to ensure tumours are treated sufficiently and improve patient outcomes.